Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5000 participants
OBSERVATIONAL
2009-03-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965
A New Prenatal Blood Test for Down Syndrome
NCT00877292
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women
Pregnant women who are scheduled to undergo an amniocentesis or CVS procedure and will receive the fetal FISH and/or karyotype results from the procedure.
Maternal blood screening test for fetal aneuploidy
One blood draw of 20 to 30 mL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Maternal blood screening test for fetal aneuploidy
One blood draw of 20 to 30 mL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant female with singleton gestation 18 years of age or older
* Subject agrees to provide a 20 to 30 mL venous blood sample
* Subject is one of the following: A) currently scheduled to undergo an amniocentesis and/or CVS procedure, OR B) currently in the first trimester of pregnancy and planning to undergo an amniocentesis in the second trimester
* Subject will receive results of a genetic analysis that includes evaluation of the fetus for aneuploidy
Exclusion Criteria
* Twins, triplets or other multiple gestation
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Obstetrix
UNKNOWN
Sequenom, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Porreco, MD
Role: PRINCIPAL_INVESTIGATOR
Obstetrix Medical Group of Colorado
Thomas J Garite, MD
Role: STUDY_DIRECTOR
Obstetrix
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Desert Good Samaritan Hospital
Mesa, Arizona, United States
Banner Good Samaritan Hospital
Phoenix, Arizona, United States
Phoenix Perinatal Associates, Phoenix Arizona Clinic
Phoenix, Arizona, United States
Obstetric Perinatal Clinic Tucson (WOMB)
Tucson, Arizona, United States
Fetal Diagnostic Center
Laguna Hills, California, United States
Long Beach Memorial Medical Center - Magella Medical Group
Long Beach, California, United States
Obstetrix Medical Group of California - Hamilton
San Jose, California, United States
Obstetrix Medical Group - Colorado at Presbyterian/St. Luke's Center
Denver, Colorado, United States
Obstetrix Medical Group Colorado - Antepartum Testing Unit at Rose Medical Center
Denver, Colorado, United States
Obstetrix Medical Group Colorada - Perinatal Resource Center at Swedish Medical Center
Englewood, Colorado, United States
Obstetrix Medical Group - Colorado at Littleton Adventist Hospital Perinatal Care Center
Littleton, Colorado, United States
Obstetrix Medical Group Colorado at Skyridge Medical Center
Lonetree, Colorado, United States
Maternal Fetal Specialists - Northside Atlanta Geogia
Atlanta, Georgia, United States
Maternal Fetal Specialist of John's Creek
Duluth, Georgia, United States
Maternal Fetal Specialists - Gwinnett
Lawrenceville, Georgia, United States
Obstetrix Medical Group of Kansas City, Missouri, Saint Luke's Perinatal Center
Kansas City, Missouri, United States
Center for Maternal Fetal Medicine - 7 Hills Office
Las Vegas, Nevada, United States
Center for Maternal Fetal Medicine - Pinto Office
Las Vegas, Nevada, United States
Center for Maternal Fetal Medicine - Post Road Office
Las Vegas, Nevada, United States
Regional Obstetrical Consultants, Chattanooga Tennessee
Chattanooga, Tennessee, United States
Regional Obstetrical Consultants, Knoxville Tennessee
Knoxville, Tennessee, United States
Texas Prenatal Group of San Antonio
San Antonio, Texas, United States
Obstetrix Medical Group of Washington, Eastside Maternal Fetal Medicine
Bellevue, Washington, United States
Obstetrix Medical Group of Washington, MFM Clinic at Evergreen Medical Center
Kirkland, Washington, United States
Obstetrix Medical Group of Washington, Inc
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SQNM-T21-301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.